Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 415 of 6351
-
Kidney cancer patients may get a drug holiday thanks to new scan technique
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and feasibility of a treatment holiday strategy directed by CD70-targeted immuno-PET/CT in patients with metastatic clear cell renal cell carcinoma (mccRCC). Specifically, the study aims to assess whether patients who achieve bo…
Phase 2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Emergency rooms may become a frontline for HIV prevention in teens
Prevention Recruiting nowScreen2Prevent is a study intended to improve HIV prevention and detection through implementation and evaluation of three different broad-scale HIV screening approaches a) targeted, b) universally offered opt-in, and c) universally offered opt-out in Emergency Departments (EDs) b…
Sponsor: Westat • Aim: Prevention
Last updated Aug 19, 2026 00:00 UTC
-
Gene therapy trial aims to fix heart muscle in rare genetic disease
Disease control Recruiting nowThis study is designed to evaluate the safety and tolerability of NVC-001 in adults with LMNA-related dilated cardiomyopathy (LMNA-DCM). The study will also assess exploratory measures of efficacy.
Phase 1/2 • Sponsor: Nuevocor Pte. Ltd. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New drug duo targets deadly brain cancer in early trial
Disease control Recruiting nowThis is a phase IB/II, open-label study evaluating CTX-009 as monotherapy and in combination with CTX-471. The study evaluates the safety and efficacy of the monotherapy and the combination in patients with recurrent glioblastoma. The study tests the hypothesis that treatment wit…
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Heart stent showdown: does adding a procedure to pills prevent more heart attacks?
Disease control Not yet recruitingComparison of the incidence of major cardiovascular events between the combination of percutaneous intervention and optimal drug therapy and the optimal drug therapy alone in patients with chronic coronary syndrome. * Main RCT (Randomized Clinical Trial): Patients with chronic c…
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug aims to boost red blood cells after transplant
Disease control Not yet recruitingAllogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective therapy for hematological malignancies. Nonetheless, poor graft function remains a life-threatening complication after allo-HSCT. Poor erythroid engraftment is associated with increased bleeding events…
Phase 2/3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a shot replace daily HIV pills? new trial tests Two-Injection combo
Disease control Recruiting nowThe study will have two parts: Part A and Part B. In Part A, the goal of the study is to compare the effectiveness of switching to the study drugs GS-3242 plus Lenacapavir (LEN) versus continuing Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF)), in virological…
Phase 2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug combo may boost surgery success in returning liver cancer
Disease control Not yet recruitingThis is a single-arm, phase II clinical study designed to evaluate the efficacy and safety of a recombinant PD-1/IL-2 bispecific antibody, as neoadjuvant therapy in hepatocellular carcinoma (HCC) patients who experienced early recurrence after curative hepatectomy and were suitab…
Phase 2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New radiation approach aims to cut treatment time for early breast cancer
Disease control Not yet recruitingThis prospective study is designed to evaluate the feasibility, efficacy, and safety of risk-stratified hypofractionated radiotherapy after breast-conserving surgery in patients with early breast cancer.
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Simpler stem cell collection could ease donor burden in Life-Threatening anemia
Disease control Not yet recruitingSevere aplastic anemia is a life-threatening bone marrow failure disorder. Haploidentical hematopoietic stem cell transplantation has become an important curative treatment option for patients who do not have an HLA-matched sibling donor. Traditionally, haploidentical transplant…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New Three-Drug cocktail aims to wipe out stomach cancer before surgery
Disease control Not yet recruitingThe purpose of this clinical trial is to evaluate whether perioperative fruquintinib combined with sintilimab and SOX is effective in treating locally advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma. The study will also assess the safety profile of this treatme…
Phase 2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Pig liver scaffold may speed healing of stubborn diabetic wounds
Disease control Recruiting nowThis study is designed to evaluate whether the Miro3D Wound Matrix, when used in addition to standard of care, improves healing outcomes in patients with chronic diabetic foot ulcers. Diabetic foot ulcers are a common and serious complication of diabetes and may be difficult to …
Sponsor: Reprise Biomedical, Inc. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New minimally invasive technique may spare spinal fracture patients from major surgery
Disease control Not yet recruitingThis study evaluates minimally invasive vertebral augmentation combined with percutaneous fixation for the treatment of severe thoracolumbar burst fractures. Traditionally, fractures with a Load Sharing Classification (LSC) score ≥7 require corpectomy, which is associated with si…
Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New drug cocktail aims to shrink Hard-to-Treat colorectal tumors
Disease control By invitation onlyA New Treatment Opportunity for Patients with Advanced Colorectal Cancer Refractory to Standard Chemotherapy: Clinical Trial of Capecitabine plus Lenvatinib Combination Therapy
Phase 1/2 • Sponsor: Seoul National University Bundang Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Spinal stimulation may restore cough power after paralysis
Disease control By invitation onlyThe overall objective of this proposal is to determine if transcutaneous spinal cord stimulation (tSCS) delivered concurrently with functional electrical stimulation (FES)-assisted cough training (FES-Cough) is an effective intervention to improve cough strength and coordination …
Sponsor: Milap Sandhu • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a new sedative make anesthesia safer for seniors?
Knowledge-focused Recruiting nowThis prospective observational cohort study evaluates the effectiveness and safety of two benzodiazepine sedatives-remimazolam and midazolam-used for general anesthesia induction in elderly patients (≥65 years) undergoing elective non-cardiac surgery. Elderly patients have reduce…
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
Mapping the Body's ICU journey: a new monitor could spot danger signs early
Knowledge-focused OngoingCritically ill patients can deteriorate rapidly across multiple organ systems. Most intensive care unit (ICU) risk tools rely on measurements collected at a single time point and may not fully capture how physiology evolves or how quickly a patient recovers from disturbance. This…
Sponsor: Shanghai Zhongshan Hospital • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
New psoriasis drug could be cheaper alternative to tremfya
Disease control Recruiting nowIt is a multicenter randomized, double-blinded, parallel, positive-controlled, Phase 3 comparative study to evaluate the efficacy and safety of QL2106 injection to Tremfya® in Patients with Moderate to Severe Plaque Psoriasis. A total of 318 subjects are planned to be included an…
Phase 3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New magnetic device aims to boost stroke recovery
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate whether low-frequency, low-intensity transcranial magnetic stimulation (ELF-MF), delivered by the I-NIC medical device, is effective and safe in treating patients with acute ischemic stroke. The study aims to answer the following qu…
Sponsor: IGEA • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for Hard-to-Treat lung cancer: drug combo may make surgery possible
Disease control Not yet recruitingThis is a multicenter, phase 2 non-randomized study to investigate the clinical feasibility and therapeutic efficacy of employing a MDT-based strategy in unresectable stage III ALK positive NSCLC following neoadjuvant alectinib in combination with platinum-based chemotherapy. Par…
Phase 2 • Sponsor: Wen-zhao ZHONG • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC